Triglyceride-Glucose Index, LDL and Cardiovascular Outcomes in Chronic Stable Cardiovascular Disease: Results from the ONTARGET and TRANSCEND trials.
Bernhard HaringHelmut SchumacherGiuseppe ManciaKoon K TeoEva M LonnFelix MahfoudRoland SchmiederJohannes F E MannKaren SliwaSalim YusufMichael BöhmPublished in: European journal of preventive cardiology (2023)
A higher TyG index is associated with a modestly increased cardiovascular risk in chronic stable cardiovascular disease. This association is largely attenuated when LDL levels are controlled.Clinical Trial Registration Information - https://www.clinicaltrials.gov; Identifier: NCT00153101.